France almost ready to launch massive trial into benefits of medical marijuana

France’s National Assembly has approved a two-year initiative that will offer an alternative treatment to 3,000 patients for whom no other options remain.

The testing will involve a six-month phase-in period, six months for patient enrollment, six months for patient treatment and monitoring, and six months for data analysis, according JD Supra, a legal website.

The study aims to help people suffering from conditions such as neuropathic pain, severe epilepsy, painful spasticity in multiple sclerosis sufferers and certain nervous system pathologies. It will also treat people in palliative care.


Is France Set To Embrace A New Cannabis-Friendly Era ?

Despite being Europe’s largest hemp producer France is reliant on imported products to satisfy the demands of its domestic CBD consumers.

But, two French entrepreneurs are determined to stand this on its head and turn France into the one of the world’s most open and compliant cannabis markets.

Aurélien Bernard and Benjamin-Alexandre Jeanroy are key supporters of the emerging French Medical Cannabis and Wellness Hemp Union (SPC). Speaking to CBD Testers they say that 2020 will be a pivotal year, as they lead on moves to change the minds of the country’s law makers.


French medical cannabis trial would initially support 3,000 patients

France is moving closer to the launch of a medical cannabis trial which could benefit 3,000 patients.

The French National Assembly is expected to give approval to the two-year trial which is being backed by president Macron’s La République En Marche majority party, reports Marijuana Business Daily.


France to begin two years of tests into medical cannabis use

Lawmakers in France, one of few European countries to still ban medical cannabis use, on Friday approved the budget for two years of medical trials that advocates hope will pave the way for a change in the law.

The National Assembly voted for the tests, already given the green light by France's ANSM medicines regulator, to be paid out of the social security budget for 2020.

"I sincerely hope that the experiments can begin in the first quarter of 2020," junior health minister Christelle Dubos said after the vote.


France’s forgotten golden age of medicinal marijuana

This past summer the French food and drug office, the Agence Nationale de Sécurité du Médicament, greenlit limited medical cannabis trials inside France, something that’s been illegal since 1953.


Epidyolex approved for use in over 30 European Countries

Patients in over 30 European countries could soon be able to get access to GW Pharmaceuticals Epidyolex cannabis medicine after it was approved by the European Commission.

Since its launch in the U.S last year GW’s sales have rocketed with Epidiolex (as it is known in America) boosting its revenues by over $30m in its first quarter, with more than 7,600 patients accessing the drug.

Now the European Medicines Agency has approved marketing authorisation in the 28 member states of the European Union, for its use for two conditions associated with childhood epilepsy; Lennox‑Gastaut syndrome and Dravet syndrome.


France forgets own golden age of medical marijuana

This past summer the French food and drug office, the Agence Nationale de Sécurité du Médicament, greenlighted limited medical cannabis trials inside France, something that’s been illegal since 1953.


10 historical figures who loved cannabis

You definitely learned a thing or two about these notable figures during your classroom studies, but we bet your teacher didn’t mention that they all smoked weed. We’re here to school you.

People love smoking weed. They always have, and they always will. So, it should come as no surprise that some of our favorite historical figures we learned about in school dabbled in the recreational (and medicinal!) cannabis scene.


France’s cannabis legalization debate misses one crucial point

Last summer in France, dozens of “CBD cafés” suddenly opened across the country.

Exploiting a legal loophole originally created for hemp farmers, these pop-up businesses sold queuing customers oils, drinks and salves infused with cannabidiol, a cannabis compound that is a faddish if unproven “cure” for insomnia, anxiety and more. The French government reacted quickly and by mid-June had officially prohibited the sale of CBD. The CBD cafés vanished within a month.


France seeks patients for medicinal cannabis trial

France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug.

The two-year experiment is being overseen by the French Agency for Drug Safety (ANSM), which drew up a 13-name committee to explore the possibilities of reform in one of Europe’s largest markets in December 2018.

International firms have been lobbying the French government to loosen its strict anti-cannabis laws, which currently make it difficult for firms to conduct any research in the country.

French patients who suffer from pain not treated by other medicines will be eligible, and the committee is looking for anyone in palliative care, epilepsy patients, and those suffering from the side effects of chemotherapy.


Subscribe to RSS - France